Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT
Clinical trial NCT00147563 · COMPLETED
Trial details
- NCT number
- NCT00147563
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2006-05-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.